Familial Dysautonomia (also called Riley–Day syndrome or hereditary sensory and autonomic neuropathy type III) is a rare condition that children are born with. It happens when a gene called ELP1 does not work normally. This gene problem harms how certain nerves develop and work, especially the nerves that feel things and the nerves that control automatic body functions like tears, blinking, blood pressure, and breathing. Because of this, the eyes and vision are often affected. MedlinePlus+1
Why the eyes are involved. In FD, the glands that make tears do not work well, the front surface of the eye (the cornea) does not feel touch or pain normally, the blink reflex can be weak, and the pupils and eye muscles can move abnormally. Over time this can cause dry eye, corneal scratches and ulcers, scars, and sometimes damage to the optic nerve (the cable that carries vision signals to the brain). These problems can reduce vision if not protected and treated carefully. EyeWikiPMC+1University of Arizona Eye Disorders
What “neuro-ophthalmic manifestations” means here
“Neuro-ophthalmic” simply means eye problems that are caused by nerve problems. In FD, the main eye-related issues come from:
-
Very low tear production (alacrima) and reduced corneal sensation (corneal hypoesthesia). This combination dries out and injures the clear “windshield” at the front of your eye (the cornea), which can lead to neurotrophic keratopathy (a poorly healing cornea), recurrent corneal erosions/ulcers, infections, and eventually corneal scarring. EyeWiki+1
-
Optic neuropathy—progressive damage to the optic nerve and loss of retinal ganglion cells (the nerve cells that carry visual signals), which slowly reduces vision over years. This is now understood to be a major reason why adults with FD can have severe vision loss. PMC+1
-
Eye movement problems (e.g., saccadic intrusions and mild ophthalmoplegia in some patients), which can affect comfortable seeing or reading. EyeWiki
There’s no cure for FD itself, but good eye care can protect vision, reduce pain and infections, and keep the cornea healthy. Treatments focus on keeping the surface of the eye wet and protected, healing the cornea, and handling nerve-related complications. Newer options aim to restore corneal nerves or stimulate healing. NCBI
Types
Below are the main “types” or buckets of eye and vision problems seen in FD. Each type is explained in simple terms.
-
Tear problems (alacrima / hypolacrima). The eyes make very few or no tears. Tears protect and smooth the eye surface, so without them the cornea dries out and gets injured more easily. Children with FD famously “cry without tears.” JAMA Network+1
-
Corneal sensation loss (corneal hypoesthesia/anesthesia). The cornea cannot feel touch or pain well. This means small scratches are not noticed and blinking does not increase to protect the eye. Scratches can grow into ulcers and scars. JAMA NetworkUniversity of Arizona Eye Disorders
-
Neurotrophic keratopathy (nerve-related corneal disease). Poor corneal nerves and lack of tears lead to slow-healing surface defects, infections, thinning, and sometimes perforation. Rare Diseases JournalPubMed
-
Eyelid and blink issues. The natural blink rate can be low, the eyelid opening can be wide, and some patients sleep with eyes partly open. This exposes the cornea to air and increases dryness. University of Arizona Eye Disorders
-
Pupil and autonomic signs. Pupils may react slowly to light, may show “light-near dissociation,” or may constrict after certain drops (e.g., methacholine) due to abnormal autonomic control. University of Arizona Eye DisordersPubMed
-
Optic nerve involvement (optic neuropathy/atrophy). Some patients develop damage to the optic nerve, which can reduce vision and cause pale optic discs on exam. Pathology studies confirm loss of optic nerve fibers in FD. AjoPMC
-
Eye movement problems (ocular motor dysfunction). Some patients have strabismus (eyes not aligned), limited eye movements (ophthalmoplegia), or unstable eye movements (nystagmus). These can blur vision or cause double vision. JAMA NetworkEyeWiki
-
Refractive errors (e.g., myopia). Nearsightedness can be more common and can add to blurry vision if not corrected. PMC
-
Surface inflammation and infection. Repeated surface injuries and poor tear protection can lead to conjunctivitis and keratitis. These conditions can become chronic without strong prevention. Rare Diseases Journal
-
Surgery and anesthesia-related risks to the eyes. During procedures, the dry, numb cornea is at special risk. Care teams must lubricate and tape the eyes shut to prevent injury. orphananesthesia.eu
Causes
Each “cause” below is a factor that creates or worsens the neuro-ophthalmic problems in FD. Several can happen at the same time.
-
ELP1 gene mutation. This is the root cause of FD. It disrupts how key sensory and autonomic neurons develop and survive. When these nerves are weak or missing, eye protection systems fail. MedlinePlus+1
-
Underactive tear glands. Tear glands do not receive normal nerve signals, so tear production is low. The cornea dries out and gets damaged more easily. JAMA Network+1
-
Loss of corneal nerve endings. Fewer or weaker corneal nerves mean reduced feeling and slower healing. Scratches are not felt and do not trigger protective blinking. JAMA Network
-
Reduced blink reflex. The automatic blink is slow or infrequent. Less blinking means less tear spreading and more exposure. University of Arizona Eye Disorders
-
Wide eyelid opening / nighttime eye exposure. The lids may not close fully, especially during sleep, leaving the cornea exposed to air. University of Arizona Eye Disorders
-
Poor tear film quality. Even when some tears are present, the layers (oil, water, mucus) can be unbalanced, so tears evaporate fast. This worsens dryness. (General FD surface disease principle supported by dry-eye literature and FD corneal disease reports.) PMCRare Diseases Journal
-
Frequent unnoticed micro-trauma. Because the cornea is numb, rubbing, dust, or a small foreign body can stay longer and dig deeper, creating ulcers. JAMA Network
-
Slow wound healing on the cornea. With poor nerves and poor tears, epithelial cells heal slowly, so tiny defects persist and grow. Rare Diseases Journal
-
Infections on a vulnerable surface. A dry, injured cornea is easier for germs to infect. Infections can lead to scars and vision loss. Rare Diseases Journal
-
Autonomic pupil problems. Abnormal pupil reactions can reflect broad autonomic nerve dysfunction in FD; this is one sign that eye-related autonomic control is impaired. University of Arizona Eye Disorders
-
Optic nerve fiber loss. Some FD patients lose retinal ganglion cells and optic nerve fibers, confirmed in clinic and pathology, which reduces signal flow to the brain. AjoPMC
-
Repeated hypoxemia during crises. FD crises can include breathing and blood pressure swings. Low oxygen could stress the optic nerve and retina over time. (Inferred contributor consistent with FD crises and optic neuropathy observations.) PMC
-
Uncorrected refractive error. Myopia or astigmatism adds blur and reduces visual function on top of surface disease. PMC
-
Strabismus and ocular motor imbalance. Misalignment can cause double vision or suppression, reducing binocular visual development in children. JAMA Network
-
Reduced Bell’s reflex / incomplete protective movements. Weaker upward eye roll when closing lids may leave the cornea more exposed during sleep or blinking. (Mechanistic inference aligned with exposure keratopathy patterns in FD.) University of Arizona Eye Disorders
-
Poor nighttime lubrication. Tear production naturally falls at night; in FD it is already low, so overnight corneal drying is worse. (Dry-eye physiology plus FD alacrima.) JAMA Network
-
Surface inflammation from chronic dryness. Long-term dryness causes inflammation that further harms nerves and surface cells, creating a harmful cycle. Rare Diseases Journal
-
Anesthesia and procedure exposure. During surgery, if eyes are not well protected, extra drying and pressure can injure the cornea. orphananesthesia.eu
-
Poor tear drainage control. Autonomic problems can also disturb tear drainage pathways and eyelid tone, adding to surface instability. (General autonomic dysfunction principle applied to ocular adnexa.) EyeWiki
-
Methacholine hypersensitivity (autonomic denervation sign). Classic pharmacologic responses highlight abnormal autonomic control of the pupil and ocular surface, reflecting the underlying nerve problem. PubMed
Common symptoms
Below are everyday signs patients, parents, or caregivers may notice. Some people have many of these; others have only a few.
-
Eyes look dry or “dull.” The surface lacks a normal wet shine because tears are few. JAMA Network
-
Little or no tearing when crying. Classic feature in babies and children: crying without tears. JAMA Network
-
Red, irritated eyes that come and go. Dryness and tiny injuries trigger redness repeatedly. Rare Diseases Journal
-
Blurry or fluctuating vision. Tear film is irregular, and the surface may be rough, so sight varies during the day. PMC
-
Sensitivity to light (photophobia). A scratched or inflamed cornea becomes light-sensitive. Rare Diseases Journal
-
Foreign-body feeling or gritty eyes. Dry surfaces feel sandy, even without a visible particle. (Notably, some patients feel less because of numbness.) JAMA Network
-
Recurrent “pink eye” or surface infections. Injured, dry surfaces get infected more easily. Rare Diseases Journal
-
Slow healing after minor eye injuries. Scratches and small defects take longer to close. Rare Diseases Journal
-
Eye pain may be less than expected. Because the cornea is numb, serious ulcers can seem oddly painless. JAMA Network
-
Nighttime eyelids partly open. Family may notice “sleeping with eyes open,” which dries the cornea. University of Arizona Eye Disorders
-
Double vision or crossed/wandering eyes. Strabismus or movement limits can cause misalignment and diplopia. JAMA Network
-
Trouble with quick or full eye movements. Some have weak or limited eye movements. EyeWiki
-
Pupils react slowly or oddly to light. This reflects autonomic nerve problems in the eye. University of Arizona Eye Disorders
-
Gradual vision loss. Scars on the cornea or damage to the optic nerve can reduce clarity and sharpness of vision. PMC
-
Frequent blinking does not increase with irritation. The normal protective blink reflex may be blunted. University of Arizona Eye Disorders
Diagnostic tests
Doctors group tests into physical exam, manual/bedside tests, laboratory/pathology tests, electrodiagnostic tests, and imaging tests.
A) Physical exam
-
External eye and eyelid inspection.
What it is: The doctor looks at the eyelids, how open they are, and how the eyes look at rest and during a blink.
What it shows in FD: Wide eyelid openings, incomplete lid closure, low blink rate, eye surface dryness, and signs of exposure. University of Arizona Eye Disorders -
Corneal reflex check (light touch blink).
What it is: A gentle touch or air puff to the cornea should make you blink.
What it shows in FD: The reflex can be weak or absent because corneal sensation is reduced. JAMA Network -
Pupil exam in light and near focus.
What it is: The doctor shines light and also asks you to focus on a near target.
What it shows in FD: Slowed light response, light-near dissociation, or unusual constriction with certain drops—signs of autonomic nerve dysfunction. University of Arizona Eye DisordersPubMed -
Eye movement and alignment exam.
What it is: Following a target in all directions and checking for straight alignment.
What it shows in FD: Strabismus, limited movements, nystagmus, or fatigue-related drift. JAMA NetworkEyeWiki
B) Manual / bedside tests
-
Schirmer tear test.
What it is: A small paper strip under the lower lid measures tear production over a few minutes.
What it shows in FD: Very low wetting confirms poor tear production (alacrima/hypolacrima). JAMA Network -
Cochet–Bonnet esthesiometry (corneal sensitivity).
What it is: A thin nylon filament lightly touches the cornea to measure feeling.
What it shows in FD: Markedly reduced corneal sensation supports the diagnosis of neurotrophic corneal disease. JAMA Network -
Fluorescein staining and slit-lamp viewing of the surface.
What it is: A harmless dye highlights scratches and dry spots; the doctor looks with a blue light microscope.
What it shows in FD: Punctate erosions, persistent epithelial defects, ulcers, or scars from chronic dryness and numbness. Rare Diseases Journal -
Eyelid closure test during sleep (caregiver observation or nighttime video).
What it is: Checking if the eyelids stay partly open at night.
What it shows in FD: Nighttime exposure that worsens dryness; guides protective steps like ointment and lid taping. orphananesthesia.eu
C) Laboratory / pathology tests
-
ELP1 gene testing for FD.
What it is: A blood or saliva test looks for the known ELP1 variants that cause FD.
What it shows in FD: Confirms the genetic cause, supports why eye nerves and tear glands developed abnormally. MedlinePlus -
Conjunctival impression cytology (surface cell sampling).
What it is: A tiny filter paper gently collects surface cells to examine under a microscope.
What it shows in FD: Loss of goblet cells and surface changes seen with severe dry eye from alacrima. (Technique widely used for severe dry eye; fits FD surface findings.) Rare Diseases Journal -
Corneal culture (when ulcers or infection are present).
What it is: A swab or scraping of an infected ulcer is sent to the lab.
What it shows in FD: Identifies germs causing keratitis so treatment can be targeted. Rare Diseases Journal -
Tear osmolarity or inflammatory markers (where available).
What it is: Tests that measure how “salty” tears are or check for inflammation.
What it shows in FD: Confirms the severity of dry eye and inflammation driving surface damage. (Dry-eye diagnostics applied to FD’s severe dry eye.) Rare Diseases Journal
D) Electrodiagnostic tests
-
Visual evoked potentials (VEP).
What it is: A test of the brain’s electrical response to visual patterns.
What it shows in FD: Delayed or reduced signals can suggest optic nerve pathway problems when optic neuropathy is suspected. PMC -
Electroretinography (ERG).
What it is: Measures the retina’s electrical response to light flashes.
What it shows in FD: Usually helps rule out primary retinal disease when vision is poor; supports that the main issue may be optic nerve or cornea. Nature -
Quantitative pupillometry.
What it is: A device measures pupil size and how fast it reacts to light.
What it shows in FD: Slow or abnormal pupil reactions that match autonomic dysfunction. University of Arizona Eye Disorders -
Blink reflex testing (neurophysiology).
What it is: Gentle electrical stimulation around the eye records the blink reflex through facial and brainstem pathways.
What it shows in FD: Abnormalities may reflect impaired sensory input and reduced protective blink. (Physiologic rationale consistent with reduced corneal reflex.) JAMA Network
E) Imaging tests
-
Anterior segment OCT (AS-OCT).
What it is: A light-based scan of the cornea and front of the eye.
What it shows in FD: Maps thinning, scarring, and nonhealing defects from neurotrophic keratopathy. Rare Diseases Journal -
In-vivo confocal microscopy.
What it is: A special microscope that can show corneal nerves and cells in living eyes.
What it shows in FD: Reduced and abnormal corneal nerves consistent with sensory loss. (Imaging that directly relates to corneal nerve loss in severe dry eye/FD.) Rare Diseases Journal -
Corneal topography / tomography.
What it is: A map of the cornea’s shape.
What it shows in FD: Irregular shape from scarring and thinning that explains vision blur; helps plan protective contact lenses if used. Rare Diseases Journal -
Optical coherence tomography of the optic nerve and macula (OCT-RNFL/GCL).
What it is: High-resolution scans of nerve fiber and ganglion cell layers.
What it shows in FD: Thinning of nerve layers when optic neuropathy/atrophy is present, matching clinical and pathology reports. PMC
Non-pharmacological treatments (therapies & “others”)
Each item includes: What it is, Purpose, and How it works.
-
Protective blinking & eyelid hygiene
What: Teach and cue regular blinking; clean lids with warm compresses and gentle lid scrubs.
Purpose: Reduce tear evaporation, remove debris, and improve the oil layer of tears.
How: Blinking spreads tears; clean lids improve meibum flow so tears last longer on the eye. -
Humidify your air + avoid fans directly to face
What: Room humidifier, especially where you sleep/work; don’t sit in front of strong air flow.
Purpose: Reduce tear evaporation.
How: Higher humidity means tears dry more slowly. -
Scheduled lubrication habit training
What: Set alarms to apply preservative-free artificial tears frequently (e.g., every 2–4 hours) and ointment at bedtime.
Purpose: Keep the corneal surface constantly wet.
How: Regular, not “as-needed,” use prevents dry spots that can turn into erosions. (Preservative-free is preferred for frequent use.) AAO JournalReview of Ophthalmology -
Moisture chamber glasses / goggles
What: Wrap-around glasses or moisture goggles (day or night).
Purpose: Trap humidity in front of the eyes.
How: They create a tiny “greenhouse” to reduce evaporation. -
Nighttime eyelid taping (short-term)
What: Gentle lid taping to ensure full closure during sleep if there is lagophthalmos (incomplete closure).
Purpose: Prevent exposure-related drying and erosions.
How: Mechanical closure seals in tears overnight. -
Bandage soft contact lens (short-term under supervision)
What: A therapeutic soft lens used like a “corneal bandage.”
Purpose: Shield the cornea to allow epithelial healing.
How: The lens covers microtrauma and reduces friction from blinking. NCBI -
Scleral lens / PROSE device (custom)
What: A large, vaulting lens filled with sterile saline.
Purpose: Creates a liquid reservoir over the cornea all day, promoting healing and comfort.
How: The lens never touches the cornea; it bathes the surface in fluid and physically protects it. Evidence supports PROSE/scleral lenses for severe ocular surface disease. EyeWikiBostonSightPMC -
Punctal occlusion (temporary plugs)
What: Tiny plugs placed into tear drains.
Purpose: Keep natural tears (and drops) on the eye longer.
How: Blocking drainage raises tear volume. (Permanent cautery is a surgical version—see surgeries.) PMC -
In-office amniotic membrane placement (e.g., PROKERA®)
What: A ring device holding cryopreserved amniotic membrane placed on the eye.
Purpose: Speed healing of non-healing corneal defects and reduce inflammation/scarring.
How: Amniotic tissue provides anti-inflammatory, anti-scarring factors and a scaffold for epithelial regrowth. EyeWikiBlue Cross NC -
Therapeutic patching (short-term)
What: Close the eye with an occlusive patch for a short time as directed.
Purpose: Reduce friction and promote epithelial closure.
How: “Rest” allows cells to migrate and seal the defect. -
Blink training + visual ergonomics for reading/screens
What: The “20-20-20” rule (breaks), bigger fonts, higher contrast, and purposeful blinking.
Purpose: Reduce strain and evaporation during focused tasks.
How: Screen time lowers blink rate; training restores it. -
Allergy control and trigger avoidance
What: Manage smoke, dust, wind, and allergens; use wrap-around eyewear outdoors.
Purpose: Lower ocular surface inflammation and irritation.
How: Fewer triggers = calmer surface = fewer erosions. -
Cold compresses for surface irritation (not infection)
What: Short, cool compresses.
Purpose: Calm surface inflammation and itch.
How: Vasoconstriction reduces inflammatory signaling. -
Protective eyewear for sports and chores
What: Safety glasses during play, yard work, or anything windy/dusty.
Purpose: Prevent microtrauma to a low-feeling cornea.
How: A barrier prevents particles striking the cornea. -
Hydration habit
What: Regular water intake throughout the day.
Purpose: Support tear production.
How: Tear film is partly water; dehydration worsens dryness. -
Sleep hygiene and side-sleep shields
What: Fix sleep apnea, avoid face-down sleeping, use eye shields if air leaks from CPAP.
Purpose: Prevent overnight drying and exposure.
How: Less airflow on eyes at night helps the cornea heal. -
Lid warming masks (for meibomian gland dysfunction)
What: 10-minute warm mask twice daily.
Purpose: Melt thickened oils so they flow better.
How: Better meibum stabilizes the tear film. -
Treat co-morbidities that worsen the ocular surface
What: Address reflux/vomiting, sinusitis, or nasal congestion that promote mouth-breathing and dryness.
Purpose: Reduce additive drying and inflammation.
How: Nasal breathing and controlled reflux help tear stability. -
Regular neuro-ophthalmology & cornea follow-up
What: Scheduled visits (often every 3–6 months, individualized).
Purpose: Catch small problems before they become ulcers/scars.
How: Slit-lamp checks, corneal sensitivity tests, and OCT help guide care. NCBI -
Low-vision rehabilitation (if optic neuropathy reduces vision)
What: Magnifiers, high-contrast lighting, large-print devices, orientation and mobility training.
Purpose: Maintain independence and safety.
How: Tools and training compensate for nerve damage while medical care protects remaining vision. (FD-related optic neuropathy is a key cause of long-term visual loss.) PMC
Drug treatments
Always use medications under an eye specialist’s guidance—especially with neurotrophic corneas.
-
Preservative-free artificial tears / gels / ointments
Class: Lubricant drops (OTC).
Dose & timing: Tears every 2–4 hrs (or more often); gel/ointment at bedtime.
Purpose: Keep the cornea constantly wet.
Mechanism: Replace and stabilize tear film layers; reduce friction.
Side effects: Temporary blur with gels/ointments; rare sensitivity. Preservative-free preferred for frequent use. AAO Journal -
Topical antibiotics during epithelial defects/ulcers
Class: Macrolide ointment (e.g., erythromycin) or fluoroquinolone drops (e.g., moxifloxacin), per clinician.
Dose & timing: Typically QID (drops) or nightly (ointment) while defect/ulcer heals.
Purpose: Prevent or treat infection when the corneal barrier is broken.
Mechanism: Kill or block bacteria on the ocular surface.
Side effects: Irritation, rare allergy; overuse can promote resistance. Ophthalmology Times -
Topical cyclosporine (e.g., 0.05–0.09%)
Class: Calcineurin inhibitor (anti-inflammatory).
Dose & timing: 1 drop BID (twice daily); effect builds over weeks.
Purpose: Reduce surface inflammation; can increase natural tear production.
Mechanism: Down-regulates T-cell-driven inflammation in the lacrimal functional unit.
Side effects: Burning/tingling on instillation; rare infection risk. AAO Journal -
Topical lifitegrast 0.5%
Class: LFA-1 antagonist (anti-inflammatory).
Dose & timing: 1 drop BID.
Purpose: Reduce dry eye inflammation.
Mechanism: Blocks LFA-1/ICAM-1 binding to interrupt T-cell recruitment.
Side effects: Temporary irritation and metallic taste (dysgeusia). AAO Journal -
Short-course topical corticosteroid (e.g., loteprednol)
Class: Ophthalmic corticosteroid.
Dose & timing: QID short bursts (days–1–2 weeks) per specialist.
Purpose: Calm acute surface inflammation unresponsive to other measures.
Mechanism: Broad anti-inflammatory effects.
Side effects: Can raise eye pressure, delay epithelial healing, and worsen infection—use cautiously and briefly. AAO Journal -
Cenegermin (recombinant human nerve growth factor)
Class: Regenerative biologic for neurotrophic keratitis.
Dose & timing: 1 drop, 6 times/day, ~2 hours apart for 8 weeks.
Purpose: Heal persistent epithelial defects in neurotrophic corneas.
Mechanism: NGF binds corneal nerve receptors, supporting nerve survival/regrowth and epithelial healing.
Side effects: Eye pain after drops, redness, tearing, swelling. FDA Access Data+1NCBI -
Hypertonic saline 5% (drops/ointment)
Class: Decongestant for corneal edema/erosion prone eyes.
Dose & timing: Drops QID and ointment at bedtime when directed.
Purpose: Pull excess fluid out of the cornea and reduce morning erosions.
Mechanism: Osmotic gradient draws water from the cornea.
Side effects: Stinging on instillation. -
Topical antihistamine/mast-cell stabilizers (if allergic component)
Class: Dual-action anti-allergy drops (e.g., olopatadine).
Dose & timing: Usually BID during allergy season.
Purpose: Reduce itch/rub cycle that injures the cornea.
Mechanism: Block histamine receptors and stabilize mast cells.
Side effects: Mild irritation; some can be drying—balance benefits/risks. -
Lubricating “mucolytic” agents with sodium hyaluronate (where available)
Class: Viscoelastic tear substitutes.
Dose & timing: QID or more.
Purpose: Longer-lasting lubrication with better surface adherence.
Mechanism: Hyaluronate binds water and clings to mucins to stabilize tear film.
Side effects: Temporary blur. -
Topical insulin drops (off-label in select refractory cases)
Class: Peptide hormone used off-label for corneal epithelial healing.
Dose & timing: Specialist-directed (often diluted insulin QID–Q6/day).
Purpose: Promote closure of persistent epithelial defects when standard therapies fail.
Mechanism: Epithelial trophic effects via growth-factor-like signaling.
Side effects: Irritation; requires compounding and close monitoring. (Evidence is growing but still limited.) EyeWiki
Important: Dry, numb corneas don’t hurt as much. Never assume “no pain = no problem.” Stick to the plan your cornea specialist gives you.
Dietary molecular supplements
Supplements can support general eye surface health, but none cure FD or optic neuropathy. Talk to your clinician, especially if you take blood thinners or have other conditions.
-
Omega-3 EPA/DHA (fish oil)
Dose: Often 1–2 g/day combined EPA+DHA with meals (if used).
Function: May improve meibum quality and some clinical signs in dry eye, though symptom benefit is inconsistent.
Mechanism: Anti-inflammatory lipid mediators that can alter tear film lipids.
Evidence note: Large RCT (DREAM) showed no symptom benefit vs. placebo; meta-analyses show mixed results. New England Journal of MedicinePMCWiley Online Library -
Vitamin A (as diet or low-dose supplement)
Dose: Meet RDA (≈700–900 µg RAE/day; avoid high doses).
Function: Supports corneal epithelium and goblet cells.
Mechanism: Regulates epithelial differentiation and mucin production.
Caution: Excess vitamin A is toxic in high doses. -
Vitamin D
Dose: Commonly 800–1000 IU/day if deficient (check level).
Function: Immune modulation; may support ocular surface.
Mechanism: Vitamin D receptors in ocular surface tissues influence inflammation. -
Vitamin C (ascorbic acid)
Dose: 500 mg/day (diet usually sufficient).
Function: Supports collagen cross-linking and wound healing.
Mechanism: Cofactor for collagen synthesis and antioxidant protection. -
Vitamin B12
Dose: 1000 µg/day (oral) for deficiency or neuropathy risk (discuss with clinician).
Function: Nerve health support; may help neuropathic symptoms.
Mechanism: Cofactor in myelin and DNA synthesis. -
Coenzyme Q10 (ubiquinone/ubiquinol)
Dose: 100–200 mg/day with fat.
Function: Mitochondrial support; theoretical benefit in optic nerve energy metabolism.
Mechanism: Electron transport chain cofactor and antioxidant. (Mechanistic rationale in FD-related ganglion cell/mitochondrial stress.) MDPI -
N-acetylcysteine (NAC)
Dose: 600 mg once or twice daily.
Function: Mucolytic and antioxidant.
Mechanism: Increases glutathione; may thin mucus and reduce oxidative stress. -
L-carnitine (acetyl-L-carnitine)
Dose: 500–1000 mg once–twice daily.
Function: Mitochondrial fatty-acid transport; studied for neuropathic symptoms.
Mechanism: Facilitates energy metabolism. -
Hyaluronic acid (oral)
Dose: 120–240 mg/day (if used).
Function: Hydration support; complements topical hyaluronate.
Mechanism: Binds water molecules; may influence tear film hydration. -
Curcumin (turmeric extract with piperine)
Dose: 500–1000 mg/day standardized extract (with piperine to improve absorption).
Function: Systemic anti-inflammatory support.
Mechanism: NF-κB pathway modulation.
Evidence reminder: Supplements are adjuncts. For dry eye in FD, surface protection and corneal healing strategies matter most.
Regenerative / biologic / “stem-cell-like” therapies
Some are approved; some are biologic or advanced therapies; a few are off-label or investigational. Your cornea specialist will tailor choices.
-
Cenegermin (Oxervate®) — approved
Dose: 1 drop 6×/day, every ~2 hours while awake, for 8 weeks.
Function: Heals neurotrophic keratitis by rescuing/regrowing corneal nerves.
Mechanism: Recombinant human nerve growth factor binds TrkA/p75NTR receptors on corneal nerves/epithelium to promote regeneration and healing.
Notes: First-in-class regenerative therapy for neurotrophic corneas. FDA Access Data+1 -
Autologous serum tears (AST) — biologic; commonly used off-label
Dose: Often 20–50% serum, 4–8×/day (customized).
Function: Provide growth factors (EGF, NGF, vitamin A) similar to natural tears.
Mechanism: Serum supplies epitheliotrophic factors that support corneal healing when regular tears fail.
Evidence: Improves symptoms and signs in severe ocular surface disease and neurotrophic keratopathy; quality of evidence varies. PMCAmerican Academy of Ophthalmology -
Platelet-rich plasma (PRP) eye drops — biologic; off-label
Dose: Compounded; typically QID–Q6/day.
Function: High concentration of growth factors to stimulate epithelial healing.
Mechanism: Platelet-derived factors (PDGF, TGF-β, VEGF) promote cell migration and proliferation.
Evidence: Case series and growing clinical use in persistent epithelial defects. -
Amniotic membrane therapy — biologic; device/surgical placement
Dose: Device (e.g., PROKERA®) placed for days; or sutured graft in OR.
Function: Anti-inflammatory, anti-scarring scaffold that speeds epithelial closure.
Mechanism: Contains heavy-chain hyaluronan and growth factors that calm inflammation and guide healing.
Status: Widely used for non-healing defects. EyeWiki -
Topical insulin (compounded) — off-label
Dose: Specialist directed (e.g., diluted regular insulin drops QID–6×/day).
Function: Stimulates epithelial cell migration in stubborn defects.
Mechanism: Growth-factor-like signaling on corneal epithelial receptors.
Evidence: RCTs and series suggest benefit in persistent epithelial defects; still not standard everywhere. EyeWiki -
Corneal neurotization (surgical nerve transfer) — surgery, not a drug, but true “regenerative” strategy
What it is: Transfer a healthy sensory nerve (directly or via graft) to re-innervate a numb cornea.
Function: Restores corneal sensation over months, improving blink reflex and healing, and reducing recurrent defects.
Mechanism: The transferred nerve grows branches into the cornea, re-establishing trophic support.
Evidence: Multiple reviews and case series show improved sensitivity and surface healing; outcomes continue to improve with technique. PubMed+1ScienceDirectPLOS
About “hard immunity boosters”: There is no approved “immune booster drug” that fixes FD or corneal numbness. The most effective “immune support” is vaccination (e.g., flu, pneumonia), good nutrition, sleep, and infection-prevention habits. For the eyes, the regenerative/biologic approaches above are the closest to “restoring function.”
Surgeries
-
Lateral tarsorrhaphy (temporary or permanent)
Procedure: Partially sew the outer eyelids together to narrow the opening.
Why: Reduce exposure and evaporation; help chronic or non-healing epithelial defects finally close. American Academy of Ophthalmology -
Permanent punctal cautery
Procedure: Permanently close tear drains with heat (after plugs prove helpful).
Why: Keep tears and drops on the eye longer in severe dry eye with fast drainage. PMC -
Amniotic membrane transplantation (in operating room)
Procedure: Suture or secure a sheet of amniotic membrane over the defect.
Why: Provide a biologic, anti-inflammatory scaffold to speed re-epithelialization and reduce scarring. EyeWiki -
Corneal neurotization
Procedure: Transfer a donor nerve (e.g., from the forehead region via graft) to the cornea.
Why: Re-establish corneal sensation in severe neurotrophic keratopathy so the eye can protect and heal itself again. PubMed+1 -
Therapeutic keratoplasty (lamellar or penetrating)
Procedure: Partial-thickness (lamellar) or full-thickness (penetrating) corneal transplant.
Why: Reserved for advanced scarring, thinning, or perforation when vision or globe integrity is threatened—only after the surface is stabilized, because healing is tough in neurotrophic eyes. Lippincott Journals
Prevention habits you can start today
-
Use preservative-free tears on a schedule (not just when it hurts). This keeps the cornea protected all day. AAO Journal
-
Wear moisture chamber glasses outdoors and in air-conditioned rooms.
-
Humidify your bedroom and avoid fans or AC directly on your face at night.
-
Night ointment + eyelid closure (tape or shields) to prevent overnight drying.
-
Protect your eyes during sports, yard work, and windy days.
-
Avoid eye rubbing—it injures a numb cornea.
-
Treat allergies to minimize itching and inflammation.
-
Address mouth-breathing and sleep issues that dry the eyes.
-
Keep follow-ups with cornea and neuro-ophthalmology—catch issues early.
-
Vaccinate and manage general health to reduce infections that can complicate FD.
When to see a doctor urgently
-
New redness, discharge, or light sensitivity—could be an ulcer/infection even if it doesn’t hurt (numb corneas feel less).
-
Any scratch or foreign body in the eye.
-
Blurred or dim vision, new blind spots, or a rapid drop in seeing.
-
Contact lens intolerance or pain with a bandage/scleral lens.
-
Non-healing surface after a few days of strict lubrication.
-
Systemic FD crises with vision symptoms—coordinate with your FD and eye teams.
What to eat and what to avoid
-
Eat: Oily fish (e.g., salmon, sardines) 1–2×/week for natural omega-3s, if not restricted.
-
Eat: Colorful vegetables (carrots, leafy greens, peppers) for vitamins A and C.
-
Eat: Nuts/seeds (walnuts, flaxseed) and olive oil for healthy fats.
-
Eat: Hydrating foods (soups, citrus, cucumbers) and drink water regularly.
-
Eat: Protein-rich meals for wound healing (fish, eggs, legumes).
-
Avoid/limit: Alcohol (dehydrating) and very salty foods (fluid shifts).
-
Avoid/limit: Highly processed snacks that stoke inflammation.
-
Avoid: Smoke exposure (irritates the ocular surface).
-
Caution: Oral antihistamines can dry the eyes—use topical options when possible (ask your doctor).
-
Supplement wisely: If you consider omega-3 or other supplements, discuss doses and interactions; evidence for symptoms is mixed, and quality matters. New England Journal of MedicinePMC
FAQs
1) Why do people with FD get eye problems?
Because the nerves that control tearing and corneal sensation don’t work normally. With fewer tears and less feeling, the cornea dries out and doesn’t heal well, so small injuries can become ulcers or scars. EyeWiki
2) Is vision loss in FD only from corneal scars?
No. Many patients also develop optic neuropathy—progressive damage to the optic nerve and ganglion cells—which is a major reason for long-term vision loss. PMC
3) If my eyes don’t hurt, can there still be danger?
Yes. A numb cornea may not feel pain, even with an ulcer. Redness, discharge, or light sensitivity are warning signs—seek care promptly.
4) Are scleral lenses safe for FD?
When fitted and monitored by experts, they’re a powerful way to bathe and protect the cornea all day and can prevent repeated erosions. EyeWiki
5) Do punctal plugs or cautery help?
They can. Blocking tear drainage keeps moisture on the eye longer and reduces drop burden. PMC
6) What is cenegermin and who needs it?
It’s a drop with nerve growth factor used 6×/day for 8 weeks to treat neurotrophic keratitis, especially when the cornea won’t heal with standard care. FDA Access Data
7) Are amniotic membranes “stem cells”?
No, but they are biologic tissues rich in healing molecules that speed epithelial repair and reduce scarring. EyeWiki
8) Can diet or fish oil cure dry eye in FD?
No. Diet supports general health. Omega-3s have mixed evidence for symptom relief; surface protection and healing strategies are the cornerstone. New England Journal of Medicine
9) Can steroids fix my dry eye?
They can calm flares short-term, but they’re not long-term solutions and can raise eye pressure or worsen infection risk—use only as directed.
10) Why might my doctor suggest tarsorrhaphy?
Partially sewing the lids reduces evaporation and helps stubborn defects heal when nothing else works. American Academy of Ophthalmology
11) What is corneal neurotization?
A surgeon transfers a healthy sensory nerve to re-innervate a numb cornea—an elegant, regenerative operation that can restore corneal feeling and reduce recurrences. PubMed
12) Will any treatment stop FD from progressing?
Current treatments protect eyes and maximize comfort/vision, but they don’t cure the underlying genetic disease. Research is ongoing. NCBI
13) How often should I be seen?
Your team will tailor this, but many people benefit from 3–6-month checks—or sooner if symptoms change.
14) Can I wear standard contact lenses?
Regular soft lenses may worsen dryness; if contacts are used, they should be therapeutic bandage lenses or properly fitted scleral lenses with close follow-up. NCBI
15) Is there hope if I already have scars?
Yes. Even with scars, careful surface care, scleral lenses, low-vision tools, and (in select cases) surgery can improve comfort and function. EyeWiki
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: August 14, 2025.